A randomized, double‐blind, phase <scp>III</scp> , multicentre study to evaluate the safety and efficacy of <scp>BF</scp> ‐200 <scp>ALA</scp> (Ameluz ^® ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the <scp>BF</scp> ‐Rhodo <scp>LED</scp> ^® lamp

Abstract

Field-directed therapy with BF-200 ALA and BF-RhodoLED lamp is highly effective and well tolerated for multiple mild-to-moderate AK lesions, providing greatly improved skin quality.